Thus, targeting Tat it is important in several respects: to prevent the establishment of infection and, in people living with HIV (PLWH), to reduce the burden of the residual disease (chronic inflammation and immune activation, early aging) commonly observed in individuals on suppressive cART [13] and responsible for the reduced quality of life and life expectancy [1]. Here, TAT is linked to infection.